Utah Medical Products Inc

NAS:UTMDHealthcareCBOEFTSE:MRUTnasdaq_composite

$74.62−0.59%LiveIn session · ≈ AED 274.04 · Market cap $237.58M

UTMD · Ratios · TradingHolo

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	60.6%	63.0%	61.6%	59.8%	59.0%	51.6%	—	—
Operating margin	32.5%	38.5%	37.9%	33.4%	33.2%	29.6%	29.6%	+0.0 pts
Net margin	25.6%	30.1%	31.5%	33.1%	33.9%	29.3%	29.3%	+0.0 pts
EBITDA margin	49.6%	53.7%	53.1%	49.3%	47.9%	44.3%	—	—
Return on equity	10.5%	13.8%	14.4%	13.0%	11.8%	9.5%	9.5%	+0.0 pts
Return on assets	9.7%	12.8%	13.3%	12.3%	11.3%	9.2%	9.2%	+0.0 pts
Return on capital employed	12.7%	16.9%	16.8%	12.8%	11.4%	9.5%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.3%	0.3%	0.3%	0.2%	0.3%	0.2%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	16.4×	19.5×	15.1×	22.6×	25.6×	37.6×	37.6×	+0.0%
Quick ratio	14.8×	17.8×	13.6×	20.5×	23.3×	34.6×	—	—
Cash ratio	13.6×	16.3×	12.6×	19.7×	22.1×	33.0×	33.0×	+0.0%
Asset turnover	0.4×	0.4×	0.4×	0.4×	0.3×	0.3×	—	—
Inventory turnover	2.7×	2.7×	2.3×	2.1×	1.9×	2.3×	—	—
Receivables turnover	10.3×	9.6×	9.4×	14.8×	10.0×	10.9×	—	—
Dividend payout	38.1%	77.5%	19.2%	25.7%	30.7%	35.3%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.